157 related articles for article (PubMed ID: 34772873)
1. Incremental Health Care Expenditures Associated With Glaucoma in the United States: A Propensity Score-matched Analysis.
Rasendran C; Li A; Singh RP
J Glaucoma; 2022 Jan; 31(1):1-7. PubMed ID: 34772873
[TBL] [Abstract][Full Text] [Related]
2. Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.
Tripathi R; Knusel KD; Ezaldein HH; Honaker JS; Bordeaux JS; Scott JF
JAMA Dermatol; 2019 Jun; 155(6):694-699. PubMed ID: 30892572
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
Daniel GW; Malone DC
J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
[TBL] [Abstract][Full Text] [Related]
4. Incremental Economic Burden of Depression in Ophthalmic Patients.
Rasendran C; Imran Y; Talcott KE
Am J Ophthalmol; 2021 Sep; 229():184-193. PubMed ID: 33845017
[TBL] [Abstract][Full Text] [Related]
5. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017.
Bounthavong M; Suh K; Li M; Spoutz PM; Stottlemyer BA; Sepassi A
Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):80. PubMed ID: 34670580
[TBL] [Abstract][Full Text] [Related]
6. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system.
Menon J; Mishra P
Osteoarthritis Cartilage; 2018 Apr; 26(4):480-484. PubMed ID: 29269328
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of vertigo and dizziness in the United States.
Ruthberg JS; Rasendran C; Kocharyan A; Mowry SE; Otteson TD
J Vestib Res; 2021; 31(2):81-90. PubMed ID: 33285661
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013.
Bounthavong M; Li M; Watanabe JH
Res Social Adm Pharm; 2017; 13(3):530-538. PubMed ID: 27263802
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL; Mathur K; Averitt AJ; Andrae DA
J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
[TBL] [Abstract][Full Text] [Related]
10. Incremental expenditure of treating hypertension in the United States.
Balu S; Thomas J
Am J Hypertens; 2006 Aug; 19(8):810-6; discussion 817. PubMed ID: 16876679
[TBL] [Abstract][Full Text] [Related]
11. Incremental direct expenditure of treating asthma in the United States.
Kamble S; Bharmal M
J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
13. Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data.
Zakeri M; Li J; Sansgiry SS; Aparasu RR
J Manag Care Spec Pharm; 2023 May; 29(5):480-489. PubMed ID: 37121258
[No Abstract] [Full Text] [Related]
14. Quantifying the Economic Impact of Depression for Spine Patients in the United States.
Ren BO; Khambete P; Rasendran C; O'Donnell JA; Ahn NU
Clin Spine Surg; 2022 Apr; 35(3):E374-E379. PubMed ID: 34183545
[TBL] [Abstract][Full Text] [Related]
15. Medical Expenditures Associated with Attention-Deficit/Hyperactivity Disorder Among Adults in the United States by Age, 2015-2019.
Witrick B; Zhang D; Su D; Li Y; McCall WV; Hendricks B; Shi L
J Gen Intern Med; 2023 Jul; 38(9):2082-2090. PubMed ID: 36781580
[TBL] [Abstract][Full Text] [Related]
16. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
Balu S
Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
[TBL] [Abstract][Full Text] [Related]
17. Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002-2011.
Echouffo-Tcheugui JB; Bishu KG; Fonarow GC; Egede LE
Am Heart J; 2017 Apr; 186():63-72. PubMed ID: 28454834
[TBL] [Abstract][Full Text] [Related]
18. Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003-2014.
Kirkland EB; Heincelman M; Bishu KG; Schumann SO; Schreiner A; Axon RN; Mauldin PD; Moran WP
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29848493
[TBL] [Abstract][Full Text] [Related]
19. Costs and cost-drivers of a diagnosis of depression among adults with epilepsy in the United States.
Lekoubou A; Bishu KG; Ovbiagele B
Epilepsy Behav; 2019 Sep; 98(Pt A):96-100. PubMed ID: 31301456
[TBL] [Abstract][Full Text] [Related]
20. Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis.
Mukherjee K; Kamal KM
Am Health Drug Benefits; 2017 Feb; 10(1):7-15. PubMed ID: 28465764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
